| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |